Source link : https://www.newshealth.biz/health-news/rsv-vaccines-will-carry-warning-for-guillain-barre-syndrome/
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination based on data from postmarketing research, according to a safety communication from the US Food and Drug Administration (FDA). Concerns about GBS arose during the review of […]
Author : News Health
Publish date : 2025-01-22 12:46:58
Copyright for syndicated content belongs to the linked Source.